24 results on '"Mesia C"'
Search Results
2. Exploring the management of elderly patients with glioblastoma using data from GEINO14-01 and EX-TEM
3. P14.58 Efficacy and safety of lomustine versus fotemustine as first and second line treament in relapsed glioblastoma patients
4. Extending temozolomide longer than six cycles in glioblastoma: Results of the randomized GEINO-014 trial
5. P1.01-54 Somatic Genome Alterations in Lung Cancer Patients Diagnosed with Li Fraumeni Syndrome
6. P14.58 Extending adjuvant temozolomide longer than six cycles doesn’t add any benefit to glioblastoma patients according to the randomized GEINO-014 TRIAL
7. Contrast enhancement in low grade gliomas: A classic prognostic factor in the molecular age
8. Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients
9. P2.07-044 Thyroid Disfunction in Advanced NSCLC Patients Treated with Nivolumab out of Clinical Trial: A Real-World Data Analysis
10. P2.08-006 Immunological Biomarkers Characterization in Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemo-Radiotherapy
11. Treatment of recurrent glioblastoma (GB) after radiotherapy (RT) and temozolomide (TMZ): A retrospective analysis of the GLIOCAT study
12. Galectin-1 (Gal-1) expression as a prognostic factor in a homogenous cohort of glioblastoma (GB) (Gliocat study)
13. Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study
14. P3-14-27: Pegylated Liposomal Doxorubicin (PLD) as Primary Treatment in Estrogen Receptor (ER) and HER2 Poor Breast Cancer and Risk of Developing Cardiotoxicity or Elderly Patients (pt). Results from the Phase II CAPRICE Study.
15. Coronary Steal Syndrome After Coronary Artery Bypass for Anomalous Aortic Origin of a Coronary Artery
16. Protocols associated with no mortality in 100 consecutive Fontan procedures☆
17. 6500 ORAL Randomized phase II trial using concomitant chemoradiation plus induction (I) or consolidation (C) chemotherapy (CT) for unresectable stage III non-small cell lung cancer (NSCLC) patients (pts). Mature results of the SLCG 0008 study
18. P-527 Phase II trial of sequential treatment with cisplatin-gemcitabinefollowed by weekly paclitaxel in the treatment of advanced lung cancer
19. P-528 Phase II trial of sequential treatment with cisplatin-gemcitabine followed by weekly paclitaxel in the treatment of advanced lung cancer
20. 61 Radiochemotherapy in the treatment of small cell lung carcinoma.Results and evaluation of acute toxicity
21. Randomized phase II study of sequential versus concurrent chemoradiotherapy (CRT) in poor- risk patients with inoperable stage III non-small cell lung cancer (NSCLC): Interim analysis
22. Transcatheter Angioplasty for Acquired Pulmonary Vein Stenosis After Radiofrequency Ablation
23. Cutting balloon angioplasty for children with small‐vessel pulmonary artery stenoses
24. Pulmonary Arterial Stiffness Response to ATP-MgCl2 and Nitric Oxide during Hypoxia Induced Pulmonary Hypertension: A Novel Approach to Assess Pulmonary Dynamics In Vivo
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.